๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The six-minute walking test in children with cystic fibrosis: Reliability and validity

โœ Scribed by V.A.M. Gulmans; N.H.M.J. van Veldhoven; K. de Meer; P.J.M. Helders


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
519 KB
Volume
22
Category
Article
ISSN
8755-6863

No coin nor oath required. For personal study only.

โœฆ Synopsis


There is a need to judge general exercise tolerance in children with cystic fibrosis (CF) under normal daily activity conditions and-when more extensive testing is required-in an exercise laboratory in a specialized center. We investigated the reproducibility, validity, and criterion for a 6-minute walking test, which simulates normal childhood activities. In Part A, we evaluated the reproducibility of a 6-minute walking test in 23 children (12 girls and 11 boys; ages 11.1 t 2.2 years; range, 8.2 15.6 years) with mild symptoms of CF [forced expiratory volume in 1 second (FEV,) 94.4 2 16.5% of predicted values (range, 60.6-129.7); body weight Z-score -0.71 2 0.81 (range, -1.73-0.93)]. The subjects performed two standardized 6-minute walking tests with 1 week between tests. There was no significant difference between the two walking distances reached (737 t 85 versus 742 % 90 meters; P = 0.56), and there was a strong correlation between the two walking distances reached by the individuals (r = 0.90, P < 0.0001).

In Part B, the validity of the walking test was evaluated in 15 children (6 girls and 9 boys; ages 14.5 If-2.0 years; range, 10.2-1 6.9 years) with moderate symptoms of CF [FEV, = 58 2 16.0% of predicted values, (range, 41.1-89.4); RVRLC ratio = 46.3 If-6.5% (range, 31.6-57.2); body weight Z-score: -1.29 t 0.60 (range, -2.20-0.14)]. They underwent standardized maximum incremental exercise testing on a cycle ergometer and a 6-minute walking test. Postexertional lactate values exceeded threshold values (as described in the literature) in all patients but one. Correlation analysis (Pearson) showed a significant correlation between the walking distance reached (WD = 697 2 104 meters), and the maximum workload ( W, , , = 118 rfs 44

Watt; r = 0.76, P < 0.001) or the maximum oxygen uptake (1,688 2 495 ml; r = 0.76, P < 0.001), the lattertwo being determined on a cycle ergometer. RVRLC Yo showed a significant negative correlation (r = -0.72, P < 0.01) with WD. Stepwise multiple regression analysis showed a multiple regression coefficient of R = 0.84 ( P < 0.001) for W , , , and RVKLC ' Yo as the independent variables vs. WD as the dependent variable. We conclude that the 6-minute walking test is a valid and useful test in children with mild to moderate symptoms of CF to assess their exercise tolerance and endurance. Exercise test results correlated negatively with pulmonary hyperinflation expressed by the RVRLC ratio.


๐Ÿ“œ SIMILAR VOLUMES


Reliability of the six-minute walk test
โœ Pankoff, Brenda A. ;Overend, Tom J. ;Lucy, S. Deborah ;White, Kevin P. ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 104 KB ๐Ÿ‘ 2 views

## Objective: To determine the test-retest reliability of the 6-minute walk test in people with fibromyalgia. ## Methods: Twenty-six subjects (27-59 years of age) performed 3 walk tests over consecutive days before and after a 4-week treatment program. reliability was determined using a one-way r

Ultrasound characteristics of the pancre
โœ Dr. W. Swobodnik; Anna Wolf; J. G. Wechsler; E. Kleihauer; H. Ditschuneit ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 671 KB

Eighteen patients (3 months to 16 years) with cystic fibrosis (CF) were examined with a real-time mechanical sector-scanner (5 MH transducer). Compared with age-matched controls, each CF patient showed morphologic changes in the pancreas on abdominal ultrasound examination. A very common finding was

Retrospective review of the effects of r
โœ J. Davies; M-T. Trindade; C. Wallis; M. Rosenthal; O. Crawford; A. Bush ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 82 KB ๐Ÿ‘ 2 views

Trials of rhDNase in mixed groups of adults and children with cystic fibrosis (CF) have demonstrated improvements in lung function and well-being. This has led to many pediatric CF patients receiving regular rhDNase therapy although their response to treatment may not be the same as that seen in adu